Searched for
AALOK SHANGHVI
ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...- Sun Pharmaceutical says it won't expand US manufacturing base amid tariff concernsSun Pharmaceutical, India's largest drug maker, is not planning to expand its manufacturing base in the US, citing sufficient existing capa...
- Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the BoardSun Pharmaceutical Industries has appointed Kirti Ganorkar as Managing Director, succeeding Dilip Shanghvi, effective September 1. Shanghvi...
- Sun Pharma elevates Aalok Shanghvi as COOSun Pharma, India's largest drugmaker, has designated Aalok Shanghvi as Chief Operating Officer. Aalok, the son of promoter Dilip Shanghvi,...
- Sun Pharma names Aalok Shanghvi as whole-time directorSun Pharma Board has appointed Aalok Shanghvi as a whole-time director for a five-year term beginning June 1, 2023. Shanghvi, the son of Su...
- Sun Pharma acquires Uractiv portfolio from Fiterman Pharma in RomaniaUractiv is the leading brand in its category in Romania, trusted by consumers for more than 10 years, Sun Pharma said in a statement.
- Sun Pharma, Hikma ink exclusive pact for plaque psoriasis drug for MENA regionUnder the terms of the licensing agreement, Hikma will be responsible for the registration and commercialisation of the product in all MENA...
- Sun Pharma posts double-digit rise in net profit, revenueSun Pharma reported total revenue from operations at Rs 8,259 crore, or 16 per cent higher.
- Sun Pharma not to regain lost reputation in a hurry: Shriram Subramanian, InGovern Research“Sun paid 6,00,000 euros as commissions to Aalok Shanghvi in 2011/12 and nobody raised a question.”
- Sun Pharma completes acquisition of 85% stake in JSC BiosintezThe process of the acquisition of 85.1 per cent of JSC Biosintez has been completed today," Sun Pharma said in a filing to BSE.
- Yashwant Mahadik to lead Sun Pharma's HR teamMahadik, 48, was senior vice president - global head of human resources business, transformation, IT and operations of Philips.
- Competition Commission approves Dilip Shanghvi's proposed Rs 1,800-crore deal with SuzlonThe deal, announced in February this year, would see Shanghvi acquiring at least 23 per cent stake in Suzlon which has been grappling with ...
- We’ll also work hard on winning the confidence of regulators, says Sun Pharma MD Dilip ShanghviOur objective would be to complete the integration in the shortest possible span of time so that we address all the uncertainties that peop...
- Ranbaxy merger: Sun Pharma readies new leadership teamKal Sundaram, who is CEO of North America business for Sun Pharma will lead the North American business for both the organisations.
- Sun Pharma executives bag top slots in company after Ranbaxy mergerMost executives from Ranbaxy's earlier team have already left the company in past one year.
- Dilip Shanghvi diversifies to expand his business, makes big investments in power and bankingThis weekend, Shanghvi announced a Rs 1,400-crore investment to pick up 23% stake in ailing renewable energy company Suzlon through DSA.
- Sun Pharmaceuticals founder Dilip Shanghvi in talks to acquire stake in Suzlon EnergyDilip Shanghvi's brother-in-law Sudhir Valia will provide Rs 4,000 crore, which the debt-hit Suzlon will use to meet its working capital ne...
- Sun Pharma-Ranbaxy deal: We will guide Ranbaxy, says Dilip ShanghviShanghvi started his entrepreneurial dreams with a loan of Rs 10,000 from his father. It’s that same instinct that’s needed at Ranbaxy now,...
- Dilip Shanghvi, Sun Pharma promoter, a pharma maven with midas touchHis staff call him India's most aggressive promoter whose calm demeanour shadows his killer instincts when it comes to splurging on riskies...
- Next generation business leaders' stock wealth rises to Rs 14K crore in 2013Stock market wealth of children of top honchos at country's listed cos rose to over Rs 14,000 cr in 2013, led by those holding shares of IT...
Load More
